Quaker Chemical (KWR) Financials

$103.75 -2.13 (-2.01%)

As of 03:58 PM Eastern

Annual Income Statements for Quaker Chemical

This table shows Quaker Chemical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	56	51	61	20	59	32	40	121	-16	113	117
Consolidated Net Income / (Loss)	58	53	63	22	60	32	40	121	-16	113	117
Net Income / (Loss) Continuing Operations	58	53	63	22	60	32	40	121	-16	113	117
Total Pre-Tax Income	78	70	84	61	83	29	27	147	7.12	153	155
Total Operating Income	77	75	85	63	88	46	59	150	52	214	195
Total Gross Profit	273	278	280	291	312	392	513	595	613	706	686
Total Revenue	766	738	747	820	868	1,134	1,418	1,761	1,944	1,953	1,840
Operating Revenue	766	738	747	820	868	1,134	1,418	1,761	1,944	1,953	1,840
Total Cost of Revenue	493	460	467	529	555	741	904	1,167	1,331	1,248	1,154
Operating Cost of Revenue	493	460	467	529	555	741	904	1,167	1,331	1,248	1,154
Total Operating Expenses	196	203	195	229	225	346	454	444	560	491	491
Selling, General & Admin Expense	196	196	194	199	208	284	381	419	464	484	485
Impairment Charge	-	-	-	-	0.00	0.00	38	0.00	93	0.00	0.00
Restructuring Charge	0.00	6.79	1.09	30	17	62	35	25	3.16	7.59	6.53
Total Other Income / (Expense), net	0.94	-4.34	-1.34	-2.08	-4.68	-17	-32	-3.48	-45	-61	-40
Interest Expense	2.37	2.59	2.89	1.36	4.04	17	27	22	33	51	41
Other Income / (Expense), net	0.77	-3.38	-0.49	-0.72	-0.64	-0.25	-5.62	19	-13	-11	1.35
Income Tax Expense	24	18	23	42	25	2.08	-5.30	35	25	56	49
Other Gains / (Losses), net	3.54	0.26	2.26	3.29	1.76	5.06	7.35	9.38	1.97	15	11
Net Income / (Loss) Attributable to Noncontrolling Interest	1.81	1.53	1.64	2.02	0.34	0.26	0.13	0.06	0.09	0.12	0.09
Basic Earnings per Share	$4.27	$3.84	$4.64	$1.53	$4.46	$2.08	$2.23	$6.79	($0.89)	$6.27	$6.51
Weighted Average Basic Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Diluted Earnings per Share	$4.26	$3.84	$4.63	$1.52	$4.45	$2.08	$2.22	$6.77	($0.89)	$6.26	$6.51
Weighted Average Diluted Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Weighted Average Basic & Diluted Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Cash Dividends to Common per Share	$1.15	$1.26	$1.36	$1.41	$1.47	$1.53	$1.56	$1.62	$1.70	$1.78	$1.88

This table shows Quaker Chemical's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	26	-76	30	29	34	20	35	35	32	14
Consolidated Net Income / (Loss)	26	-76	30	29	34	20	35	35	32	14
Net Income / (Loss) Continuing Operations	26	-76	30	29	34	20	35	35	32	14
Total Pre-Tax Income	36	-68	34	40	44	34	46	48	42	19
Total Operating Income	45	-54	50	57	60	48	56	58	52	29
Total Gross Profit	161	156	173	178	183	171	182	176	173	156
Total Revenue	492	485	500	495	491	467	470	464	462	444
Operating Revenue	492	485	500	495	491	467	470	464	462	444
Total Cost of Revenue	331	329	327	318	307	296	288	288	290	288
Operating Cost of Revenue	331	329	327	318	307	296	288	288	290	288
Total Operating Expenses	116	210	124	121	124	123	126	117	121	127
Selling, General & Admin Expense	115	121	120	120	123	121	124	117	118	125
Restructuring Charge	0.68	-4.23	3.97	1.04	1.02	1.55	1.86	0.32	2.61	1.74
Total Other Income / (Expense), net	-8.30	-14	-15	-16	-15	-14	-9.74	-10	-9.56	-10
Interest Expense	8.39	12	13	13	13	12	11	11	10	9.08
Other Income / (Expense), net	0.09	-2.09	-2.24	-3.61	-2.71	-2.11	1.08	0.42	0.78	-0.93
Income Tax Expense	10	11	9.53	14	14	19	13	16	12	8.85
Other Gains / (Losses), net	-0.21	2.61	4.63	2.76	3.28	4.67	1.98	2.57	2.39	4.03
Net Income / (Loss) Attributable to Noncontrolling Interest	0.04	0.02	0.01	0.05	0.04	0.03	0.03	0.03	0.03	0.00
Basic Earnings per Share	$1.44	($4.24)	$1.64	$1.63	$1.87	$1.13	$1.96	$1.94	$1.81	$0.80
Weighted Average Basic Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M
Diluted Earnings per Share	$1.44	($4.24)	$1.64	$1.63	$1.87	$1.12	$1.95	$1.94	$1.81	$0.81
Weighted Average Diluted Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M
Weighted Average Basic & Diluted Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M

This table details how cash moves in and out of Quaker Chemical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-3.76	16	-4.20	-39	13	66	38	-17	16	14	-5.65
Net Cash From Operating Activities	55	73	63	65	79	82	178	49	42	279	205
Net Cash From Continuing Operating Activities	55	73	74	26	79	129	178	49	42	279	205
Net Income / (Loss) Continuing Operations	58	53	63	22	60	32	40	121	-16	113	117
Consolidated Net Income / (Loss)	58	53	63	22	60	32	40	121	-16	113	117
Depreciation Expense	12	12	13	20	20	45	83	87	80	82	84
Amortization Expense	4.33	6.81	7.01	0.24	0.07	1.98	4.75	4.75	2.94	1.41	1.41
Non-Cash Adjustments To Reconcile Net Income	0.15	14	-0.02	4.62	6.04	27	60	-9.62	100	7.01	11
Changes in Operating Assets and Liabilities, net	-20	-12	-20	-22	-6.89	24	-9.18	-154	-125	76	-8.83
Net Cash From Investing Activities	-84	-34	-25	-15	-12	-909	-71	-49	-40	-28	-76
Net Cash From Continuing Investing Activities	-84	-34	-25	-15	-12	-909	-71	-49	-40	-28	-76
Purchase of Property, Plant & Equipment	-13	-11	-9.95	-11	-13	-16	-18	-21	-29	-39	-42
Acquisitions	-74	-24	-15	-5.36	-0.50	-893	-56	-42	-13	0.00	-39
Sale of Property, Plant & Equipment	0.20	0.14	0.19	1.58	0.87	0.10	2.70	15	1.46	11	4.68
Net Cash From Financing Activities	30	-17	-38	-55	-47	844	-75	-13	25	-239	-123
Net Cash From Continuing Financing Activities	30	-17	-38	-55	-47	844	-75	-13	25	-239	-123
Repayment of Debt	-1.37	-0.48	-15	-2.85	-27	115	-50	14	-695	-204	-38
Repurchase of Common Equity	0.00	-7.28	-5.86	-32	0.00	0.00	-1.05	-	0.00	0.00	-49
Payment of Dividends	-16	-17	-18	-19	-20	-22	-28	-29	-30	-32	-33
Issuance of Debt	59	6.16	0.00	0.00	0.00	750	0.00	0.00	750	0.00	0.00
Issuance of Common Equity	0.80	1.05	-0.81	-1.96	0.08	1.37	3.87	0.89	-0.38	-2.75	-2.38
Effect of Exchange Rate Changes	-4.14	-6.02	-4.09	5.40	-6.14	1.26	6.59	-3.06	-10	0.77	-11
Cash Interest Paid	1.89	2.22	2.48	2.77	2.42	20	24	19	29	55	45
Cash Income Taxes Paid	23	21	25	22	20	15	20	35	35	57	61

This table details how cash moves in and out of Quaker Chemical's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-63	42	8.91	-0.47	8.95	-3.83	1.22	-7.18	24	-23
Net Cash From Operating Activities	-18	68	38	78	83	80	27	46	68	63
Net Cash From Continuing Operating Activities	-18	68	38	78	83	80	27	46	68	63
Net Income / (Loss) Continuing Operations	26	-76	30	29	34	20	35	35	32	14
Consolidated Net Income / (Loss)	26	-76	30	29	34	20	35	35	32	14
Depreciation Expense	20	20	20	21	21	21	21	21	21	21
Amortization Expense	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35
Non-Cash Adjustments To Reconcile Net Income	-2.68	93	2.68	5.23	-0.18	-0.72	3.52	1.58	9.20	-3.14
Changes in Operating Assets and Liabilities, net	-61	30	-15	23	29	39	-33	-12	4.88	31
Net Cash From Investing Activities	-5.15	-11	-6.16	-11	-8.75	-1.83	-29	-3.92	-23	-21
Net Cash From Continuing Investing Activities	-5.15	-11	-6.16	-11	-8.75	-1.83	-29	-3.92	-23	-21
Purchase of Property, Plant & Equipment	-5.09	-8.31	-6.16	-11	-8.75	-13	-4.46	-6.66	-8.21	-22
Sale of Property, Plant & Equipment	-0.02	1.40	0.00	-	-	11	0.06	2.74	-	1.88
Net Cash From Financing Activities	-32	-22	-25	-64	-62	-88	6.56	-46	-28	-56
Net Cash From Continuing Financing Activities	-32	-22	-25	-64	-62	-88	6.56	-46	-28	-56
Repayment of Debt	-25	-14	-15	-58	-53	-78	16	-30	-5.27	-19
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-15	-26
Payment of Dividends	-7.44	-7.80	-7.81	-7.82	-7.83	-8.19	-8.19	-8.19	-8.15	-8.65
Issuance of Common Equity	0.21	0.24	-2.11	1.40	-0.24	-1.80	-1.44	-0.05	0.86	-1.75
Effect of Exchange Rate Changes	-8.37	6.48	2.15	-3.71	-4.19	6.52	-3.27	-3.70	5.85	-10

This table presents Quaker Chemical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	666	681	692	722	710	2,850	2,892	2,956	2,822	2,714	2,611
Total Current Assets	352	358	376	407	419	716	793	920	994	928	876
Cash & Equivalents	65	81	89	90	104	124	182	165	181	195	189
Accounts Receivable	189	188	195	208	202	376	373	431	473	445	400
Inventories, net	78	75	77	87	94	175	188	265	285	234	227
Prepaid Expenses	11	14	15	21	18	42	50	60	55	55	60
Plant, Property, & Equipment, net	86	88	86	87	84	213	204	198	199	208	230
Total Noncurrent Assets	228	235	230	229	207	1,921	1,895	1,838	1,629	1,579	1,505
Long-Term Investments	22	20	23	26	21	94	96	95	88	101	98
Goodwill	78	79	81	86	83	607	631	631	515	513	519
Intangible Assets	70	73	73	72	64	1,122	1,081	1,028	943	897	827
Noncurrent Deferred & Refundable Income Taxes	24	30	24	15	6.95	15	17	16	11	11	9.22
Other Noncurrent Operating Assets	34	32	29	30	32	83	70	68	72	57	51
Total Liabilities & Shareholders' Equity	666	681	692	722	710	2,850	2,892	2,956	2,822	2,714	2,611
Total Liabilities	300	299	279	313	273	1,608	1,571	1,568	1,543	1,329	1,256
Total Current Liabilities	125	125	127	155	151	360	383	430	355	368	380
Short-Term Debt	0.40	0.66	0.71	5.74	0.67	38	39	57	19	23	38
Accounts Payable	75	67	78	93	88	164	192	227	194	185	198
Accrued Expenses	-	-	-	-	26	46	43	38	40	55	50
Dividends Payable	3.99	4.25	4.58	4.72	4.94	6.83	7.05	7.43	7.81	8.19	8.57
Current Employee Benefit Liabilities	21	20	19	24	1.21	3.41	1.47	1.55	1.56	2.21	2.33
Other Current Liabilities	24	32	24	27	31	102	100	100	92	94	83
Total Noncurrent Liabilities	175	175	114	158	122	1,248	1,188	1,137	1,188	962	877
Long-Term Debt	75	81	66	61	36	882	849	836	934	731	670
Capital Lease Obligations	-	-	-	-	0.00	31	27	-	27	23	20
Noncurrent Deferred & Payable Income Tax Liabilities	8.58	10	12	9.65	10	211	193	179	160	147	139
Noncurrent Employee Benefit Liabilities	46	41	0.00	36	32	57	64	46	29	29	24
Other Noncurrent Operating Liabilities	45	43	36	51	44	66	55	76	39	32	24
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	365	381	413	410	436	1,242	1,321	1,388	1,279	1,385	1,354
Total Preferred & Common Equity	357	373	403	408	435	1,241	1,320	1,387	1,278	1,384	1,354
Total Common Equity	357	373	403	408	435	1,241	1,320	1,387	1,278	1,384	1,354
Common Stock	112	120	126	107	111	906	923	935	946	958	921
Retained Earnings	300	327	364	366	405	413	424	516	470	551	634
Accumulated Other Comprehensive Income / (Loss)	-54	-73	-87	-65	-81	-78	-27	-64	-138	-124	-202
Noncontrolling Interest	7.66	8.20	9.85	1.95	1.32	1.60	0.55	0.63	0.67	0.60	0.62

This table presents Quaker Chemical's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,832	2,858	2,790	2,733	2,714	2,672	2,736
Total Current Assets	985	1,029	984	966	933	919	942
Cash & Equivalents	139	190	189	198	196	189	212
Accounts Receivable	462	483	454	446	440	424	423
Inventories, net	317	293	275	251	240	239	245
Prepaid Expenses	67	63	65	71	57	67	62
Plant, Property, & Equipment, net	188	203	205	196	202	201	216
Plant, Property & Equipment, gross	426	439	442	432	445	448	474
Accumulated Depreciation	237	236	237	235	243	247	259
Total Noncurrent Assets	1,658	1,626	1,602	1,570	1,579	1,552	1,578
Long-Term Investments	77	91	92	93	100	96	103
Goodwill	591	517	507	504	523	518	533
Intangible Assets	916	936	918	890	886	866	875
Noncurrent Deferred & Refundable Income Taxes	11	10	10	9.57	10	13	12
Other Noncurrent Operating Assets	64	71	74	72	60	60	55
Total Liabilities & Shareholders' Equity	2,832	2,858	2,790	2,733	2,714	2,672	2,736
Total Liabilities	1,552	1,542	1,454	1,391	1,323	1,277	1,289
Total Current Liabilities	366	369	347	352	350	350	371
Short-Term Debt	20	19	19	19	28	32	39
Accounts Payable	209	217	194	190	191	185	192
Accrued Expenses	33	27	35	44	28	32	39
Dividends Payable	7.80	7.82	7.83	8.19	8.19	8.16	8.66
Current Employee Benefit Liabilities	1.54	1.57	1.58	1.57	2.21	2.19	2.18
Other Current Liabilities	94	97	89	89	93	90	91
Total Noncurrent Liabilities	1,186	1,172	1,107	1,039	972	927	918
Long-Term Debt	931	922	864	805	740	704	701
Capital Lease Obligations	26	-	-	-	23	22	21
Noncurrent Deferred & Payable Income Tax Liabilities	151	158	156	152	151	147	143
Noncurrent Employee Benefit Liabilities	38	29	29	27	29	28	26
Other Noncurrent Operating Liabilities	40	64	58	55	30	26	28
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,280	1,317	1,337	1,341	1,392	1,396	1,446
Total Preferred & Common Equity	1,279	1,316	1,336	1,340	1,391	1,395	1,446
Total Common Equity	1,279	1,316	1,336	1,340	1,391	1,395	1,446
Common Stock	943	948	953	956	961	956	946
Retained Earnings	554	492	513	539	578	604	628
Accumulated Other Comprehensive Income / (Loss)	-218	-123	-130	-155	-147	-166	-128
Noncontrolling Interest	0.63	0.68	0.69	0.72	0.56	0.59	0.61

This table displays calculated financial ratios and metrics derived from Quaker Chemical's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.00%	-3.70%	1.24%	9.83%	5.78%	30.66%	25.07%	24.23%	10.36%	0.50%	-5.82%
EBITDA Growth	4.65%	-4.60%	15.52%	-21.25%	403.48%	-56.63%	52.81%	83.87%	-52.76%	133.31%	-1.96%
EBIT Growth	4.50%	-8.87%	19.20%	-26.91%	180.98%	-73.67%	17.14%	215.06%	-76.55%	413.45%	-3.81%
NOPAT Growth	5.66%	2.93%	10.90%	-68.16%	423.62%	-30.19%	65.73%	61.68%	-214.08%	204.42%	-2.80%
Net Income Growth	-0.94%	-9.59%	19.61%	-64.63%	336.42%	-46.69%	24.79%	205.20%	-113.05%	812.49%	3.42%
EPS Growth	-0.23%	-9.86%	20.57%	-67.17%	385.53%	-53.26%	6.73%	204.96%	-113.15%	803.37%	3.99%
Operating Cash Flow Growth	-25.90%	34.27%	-14.51%	3.16%	21.64%	4.56%	116.56%	-72.57%	-14.59%	567.61%	-26.68%
Free Cash Flow Firm Growth	-153.50%	288.07%	-65.57%	297.70%	-1,048.18%	-344.68%	107.23%	-41.92%	-291.82%	360.27%	-21.22%
Invested Capital Growth	28.53%	2.18%	12.36%	-11.15%	-7.18%	181.45%	-0.93%	3.19%	-1.54%	-6.14%	-3.81%
Revenue Q/Q Growth	1.29%	-1.44%	1.08%	2.48%	0.09%	18.85%	-0.38%	3.60%	1.98%	-0.90%	-1.24%
EBITDA Q/Q Growth	0.73%	-3.41%	-46.27%	-2.89%	272.20%	23.57%	27.40%	-7.31%	-41.72%	55.59%	-5.90%
EBIT Q/Q Growth	-0.12%	-4.61%	-63.46%	-4.50%	210.72%	0.78%	137.20%	-11.15%	-68.41%	99.85%	-8.43%
NOPAT Q/Q Growth	-0.38%	3.19%	6.80%	-59.23%	93.91%	60.79%	125.57%	-10.37%	-223.87%	1,697.25%	-4.94%
Net Income Q/Q Growth	-2.92%	-2.00%	10.69%	-55.04%	81.01%	30.40%	503.56%	-20.01%	-120.25%	575.80%	-4.92%
EPS Q/Q Growth	-2.29%	-2.78%	11.03%	-57.18%	83.44%	4.52%	1,133.33%	-20.17%	-120.41%	595.56%	-4.55%
Operating Cash Flow Q/Q Growth	-8.68%	8.84%	-16.95%	27.99%	5.24%	30.01%	12.23%	-28.93%	107.61%	4.29%	-7.46%
Free Cash Flow Firm Q/Q Growth	-44.55%	62.28%	-96.61%	162.77%	-990.85%	16.54%	726.06%	214.28%	-182.39%	48.21%	66.77%
Invested Capital Q/Q Growth	4.11%	-0.68%	11.94%	-6.47%	188.47%	6.05%	3.92%	-1.76%	-2.56%	-0.41%	-5.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.67%	37.66%	37.51%	35.54%	72.00%	34.59%	36.22%	33.76%	31.52%	36.13%	37.29%
EBITDA Margin	12.37%	12.26%	13.99%	10.03%	24.65%	8.18%	10.00%	14.80%	6.33%	14.70%	15.31%
Operating Margin	10.10%	10.11%	11.43%	7.65%	20.24%	4.07%	4.19%	8.54%	2.69%	10.98%	10.58%
EBIT Margin	10.20%	9.65%	11.37%	7.56%	20.09%	4.05%	3.79%	9.61%	2.04%	10.43%	10.66%
Profit (Net Income) Margin	7.61%	7.15%	8.44%	2.72%	13.79%	2.81%	2.81%	6.90%	-0.82%	5.78%	6.35%
Tax Burden Percent	74.46%	75.05%	75.04%	36.76%	143.95%	110.31%	146.60%	82.61%	-222.56%	73.71%	75.28%
Interest Burden Percent	100.22%	98.65%	99.00%	97.81%	190.73%	63.00%	50.50%	86.81%	17.93%	75.13%	79.09%
Effective Tax Rate	30.07%	25.32%	27.65%	68.66%	60.29%	7.21%	-19.51%	23.77%	350.17%	36.30%	31.79%
Return on Invested Capital (ROIC)	16.98%	15.37%	15.88%	5.06%	17.08%	3.18%	3.59%	5.74%	-6.50%	7.06%	7.22%
ROIC Less NNEP Spread (ROIC-NNEP)	5.42%	42.68%	0.03%	-6.60%	38.91%	-0.62%	-0.90%	6.79%	10.43%	3.12%	3.80%
Return on Net Nonoperating Assets (RNNOA)	-0.55%	-1.25%	0.00%	0.36%	-5.88%	-0.21%	-0.49%	3.22%	5.31%	1.42%	1.30%
Return on Equity (ROE)	16.43%	14.12%	15.88%	5.42%	28.28%	2.97%	3.10%	8.97%	-1.19%	8.48%	8.52%
Cash Return on Invested Capital (CROIC)	-7.99%	13.21%	4.24%	16.87%	-153.49%	-91.95%	4.53%	2.60%	-4.95%	13.39%	11.10%
Operating Return on Assets (OROA)	12.50%	10.58%	12.36%	8.77%	24.34%	2.58%	1.87%	5.79%	1.37%	7.36%	7.36%
Return on Assets (ROA)	9.33%	7.83%	9.18%	3.15%	16.71%	1.79%	1.39%	4.15%	-0.55%	4.08%	4.38%
Return on Common Equity (ROCE)	16.04%	13.82%	15.52%	5.35%	28.17%	2.97%	3.10%	8.96%	-1.19%	8.47%	8.52%
Return on Equity Simple (ROE_SIMPLE)	16.31%	14.13%	15.65%	5.47%	13.75%	2.57%	3.01%	8.75%	-1.24%	8.15%	8.62%
Net Operating Profit after Tax (NOPAT)	54	56	62	20	61	43	71	115	-131	137	133
NOPAT Margin	7.06%	7.55%	8.27%	2.40%	14.14%	3.78%	5.00%	6.51%	-6.73%	6.99%	7.22%
Net Nonoperating Expense Percent (NNEP)	11.56%	-27.31%	15.85%	11.66%	-2.36%	3.81%	4.50%	-1.05%	-16.93%	3.93%	3.43%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-5.79%	6.32%	6.38%
Cost of Revenue to Revenue	64.33%	62.34%	62.49%	64.46%	128.00%	65.41%	63.78%	66.24%	68.48%	63.87%	62.71%
SG&A Expenses to Revenue	25.57%	26.63%	25.94%	24.24%	47.92%	25.04%	26.86%	23.78%	23.88%	24.76%	26.35%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.57%	27.55%	26.08%	27.89%	51.76%	30.52%	32.03%	25.22%	28.83%	25.14%	26.71%
Earnings before Interest and Taxes (EBIT)	78	71	85	62	174	46	54	169	40	204	196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	95	90	104	82	214	93	142	261	123	287	282
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.08	2.52	3.93	4.63	5.17	2.25	3.31	2.90	2.29	2.74	1.84
Price to Tangible Book Value (P/TBV)	5.27	4.26	6.35	7.55	7.81	0.00	0.00	0.00	0.00	0.00	329.33
Price to Revenue (P/Rev)	1.44	1.28	2.12	2.30	2.59	2.47	3.08	2.28	1.50	1.94	1.36
Price to Earnings (P/E)	19.50	18.38	25.75	93.12	37.85	88.36	110.11	33.10	0.00	33.58	21.39
Dividend Yield	1.33%	1.75%	1.40%	0.99%	1.71%	0.96%	0.63%	0.71%	1.03%	0.84%	1.32%
Earnings Yield	5.13%	5.44%	3.88%	1.07%	2.64%	1.13%	0.91%	3.02%	0.00%	2.98%	4.68%
Enterprise Value to Invested Capital (EV/IC)	3.06	2.54	3.76	5.04	6.14	1.78	2.55	2.29	1.82	2.28	1.63
Enterprise Value to Revenue (EV/Rev)	1.43	1.26	2.07	2.25	2.49	3.11	3.53	2.64	1.87	2.19	1.60
Enterprise Value to EBITDA (EV/EBITDA)	11.59	10.28	14.80	22.39	20.23	38.06	35.31	17.85	29.52	14.86	10.43
Enterprise Value to EBIT (EV/EBIT)	14.06	13.06	18.22	29.69	24.83	76.95	93.13	27.47	91.56	20.94	14.97
Enterprise Value to NOPAT (EV/NOPAT)	20.30	16.70	25.03	93.64	35.28	82.48	70.55	40.55	0.00	31.24	22.11
Enterprise Value to Operating Cash Flow (EV/OCF)	20.08	12.66	24.63	28.43	27.46	42.86	28.06	95.05	86.96	15.30	14.35
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	19.42	93.80	28.09	0.00	0.00	55.99	89.59	0.00	16.47	14.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.21	0.22	0.16	0.16	0.17	0.77	0.69	0.64	0.77	0.56	0.54
Long-Term Debt to Equity	0.21	0.21	0.16	0.15	0.16	0.74	0.66	0.60	0.75	0.54	0.51
Financial Leverage	-0.10	-0.03	-0.02	-0.06	-0.30	0.34	0.54	0.47	0.51	0.45	0.34
Leverage Ratio	1.76	1.80	1.73	1.72	3.39	2.12	2.24	2.16	2.17	2.08	1.94
Compound Leverage Factor	1.76	1.78	1.71	1.68	3.23	1.34	1.13	1.87	0.39	1.56	1.54
Debt to Total Capital	17.18%	17.72%	13.88%	14.02%	15.48%	43.38%	40.93%	39.16%	43.38%	35.94%	34.94%
Short-Term Debt to Total Capital	0.09%	0.14%	0.15%	1.20%	0.28%	1.75%	1.74%	2.50%	0.85%	1.08%	1.80%
Long-Term Debt to Total Capital	17.09%	17.58%	13.73%	12.82%	15.20%	41.64%	39.18%	36.66%	42.53%	34.86%	33.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.74%	1.77%	2.06%	0.41%	0.56%	0.07%	0.02%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	81.08%	80.51%	84.07%	85.57%	183.96%	56.54%	59.05%	60.81%	56.59%	64.03%	65.03%
Debt to EBITDA	0.80	0.91	0.64	0.81	0.34	10.26	6.46	3.43	7.96	2.71	2.58
Net Debt to EBITDA	-0.11	-0.21	-0.43	-0.59	-0.83	7.92	4.50	2.43	5.77	1.68	1.56
Long-Term Debt to EBITDA	0.80	0.90	0.63	0.74	0.34	9.85	6.18	3.21	7.80	2.62	2.45
Debt to NOPAT	1.40	1.47	1.08	3.40	0.60	22.24	12.90	7.79	-7.49	5.69	5.48
Net Debt to NOPAT	-0.20	-0.35	-0.73	-2.48	-2.90	17.16	8.99	5.52	-5.43	3.52	3.32
Long-Term Debt to NOPAT	1.39	1.46	1.07	3.11	1.17	21.34	12.35	7.29	-7.34	5.52	5.19
Altman Z-Score	4.78	4.40	6.05	6.17	7.82	1.85	2.59	2.77	2.38	3.21	2.71
Noncontrolling Interest Sharing Ratio	2.33%	2.12%	2.27%	1.43%	0.39%	0.17%	0.08%	0.04%	0.05%	0.05%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.81	2.88	2.95	2.63	2.76	1.99	2.07	2.14	2.80	2.52	2.31
Quick Ratio	2.04	2.16	2.23	1.93	2.02	1.39	1.45	1.38	1.84	1.74	1.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-25	48	16	66	-278	-1,236	89	52	-100	259	204
Operating Cash Flow to CapEx	425.57%	673.81%	642.68%	696.74%	655.40%	533.44%	1,173.69%	728.93%	154.36%	1,010.17%	551.16%
Free Cash Flow to Firm to Interest Expense	-10.74	18.52	5.71	48.27	-68.79	-72.82	3.36	2.33	-3.06	5.11	4.98
Operating Cash Flow to Interest Expense	23.07	28.41	21.73	47.69	19.49	4.85	6.71	2.19	1.28	5.50	4.99
Operating Cash Flow Less CapEx to Interest Expense	17.65	24.19	18.35	40.84	16.52	3.94	6.13	1.89	0.45	4.96	4.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.23	1.10	1.09	1.16	2.42	0.64	0.49	0.60	0.67	0.71	0.69
Accounts Receivable Turnover	4.31	3.90	3.89	4.06	8.45	3.92	3.79	4.38	4.30	4.26	4.35
Inventory Turnover	6.60	6.02	6.13	6.43	12.25	5.51	4.99	5.16	4.85	4.81	5.00
Fixed Asset Turnover	8.94	8.51	8.61	9.51	20.34	7.62	6.79	8.78	9.81	9.61	8.41
Accounts Payable Turnover	6.69	6.46	6.44	6.20	12.28	5.89	5.08	5.58	6.33	6.59	6.03
Days Sales Outstanding (DSO)	84.62	93.48	93.74	89.81	172.71	93.08	96.41	83.28	84.84	85.75	83.83
Days Inventory Outstanding (DIO)	55.29	60.65	59.53	56.73	119.20	66.23	73.21	70.76	75.33	75.87	72.98
Days Payable Outstanding (DPO)	54.55	56.47	56.67	58.90	120.50	62.01	71.84	65.47	57.68	55.41	60.58
Cash Conversion Cycle (CCC)	85.36	97.66	96.60	87.64	173.03	97.29	97.79	88.57	102.50	106.22	96.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	358	366	411	366	705	1,984	1,965	2,028	1,997	1,874	1,803
Invested Capital Turnover	2.40	2.04	1.92	2.11	4.85	0.84	0.72	0.88	0.97	1.01	1.00
Increase / (Decrease) in Invested Capital	80	7.82	45	-46	679	1,279	-18	63	-31	-123	-71
Enterprise Value (EV)	1,098	930	1,546	1,841	2,164	3,531	5,005	4,651	3,635	4,268	2,936
Market Capitalization	1,101	941	1,581	1,888	4,613	2,794	4,367	4,017	2,923	3,786	2,495
Book Value per Share	$26.94	$28.04	$30.38	$30.65	$32.63	$69.97	$74.05	$77.53	$71.27	$76.97	$76.10
Tangible Book Value per Share	$15.76	$16.58	$18.77	$18.80	$21.61	($27.53)	($22.00)	($15.18)	($10.04)	($1.39)	$0.43
Total Capital	441	463	479	476	946	2,194	2,236	2,281	2,258	2,162	2,081
Total Debt	76	82	66	67	73	952	915	893	980	777	727
Total Long-Term Debt	75	81	66	61	72	914	876	836	961	754	690
Net Debt	-11	-19	-45	-49	-178	735	637	633	711	481	440
Capital Expenditures (CapEx)	13	11	9.77	9.30	24	15	15	6.71	27	28	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	162	153	161	168	327	271	267	382	478	389	345
Debt-free Net Working Capital (DFNWC)	227	234	250	258	535	394	449	547	659	584	534
Net Working Capital (NWC)	227	234	249	252	534	356	410	490	639	560	497
Net Nonoperating Expense (NNE)	-4.20	2.98	-1.28	-2.63	1.51	11	31	-6.73	-115	24	16
Net Nonoperating Obligations (NNO)	-6.76	-15	-1.14	-44	-168	742	645	640	718	490	449
Total Depreciation and Amortization (D&A)	17	19	20	20	40	47	88	91	83	83	86
Debt-free, Cash-free Net Working Capital to Revenue	21.19%	20.76%	21.56%	20.45%	18.85%	23.89%	18.83%	21.66%	24.57%	19.93%	18.77%
Debt-free Net Working Capital to Revenue	29.64%	31.75%	33.45%	31.41%	30.86%	34.79%	31.65%	31.04%	33.89%	29.89%	29.04%
Net Working Capital to Revenue	29.59%	31.66%	33.36%	30.71%	30.78%	31.41%	28.90%	27.81%	32.90%	28.69%	27.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.27	$3.84	$4.64	$1.53	$4.46	$2.08	$2.23	$6.79	($0.89)	$6.27	$6.51
Adjusted Weighted Average Basic Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Adjusted Diluted Earnings per Share	$4.26	$3.84	$4.63	$1.52	$4.45	$2.08	$2.22	$6.77	($0.89)	$6.26	$6.51
Adjusted Weighted Average Diluted Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.30M	13.21M	13.28M	13.31M	13.34M	17.73M	17.85M	17.90M	17.95M	17.99M	17.67M
Normalized Net Operating Profit after Tax (NOPAT)	54	61	63	65	73	100	93	134	104	141	137
Normalized NOPAT Margin	7.06%	8.24%	8.38%	7.91%	16.82%	8.86%	6.55%	7.61%	5.35%	7.24%	7.46%
Pre Tax Income Margin	10.22%	9.52%	11.25%	7.40%	19.16%	2.55%	1.91%	8.35%	0.37%	7.84%	8.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	32.95	27.54	29.37	45.67	21.56	2.70	2.02	7.58	1.22	4.02	4.78
NOPAT to Interest Expense	22.82	21.54	21.38	14.48	15.17	2.52	2.67	5.14	-4.02	2.70	3.24
EBIT Less CapEx to Interest Expense	27.53	23.32	25.99	38.83	18.59	1.79	1.45	7.28	0.39	3.48	3.88
NOPAT Less CapEx to Interest Expense	17.40	17.33	18.00	7.64	12.20	1.61	2.10	4.84	-4.85	2.15	2.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.08%	31.33%	27.96%	83.47%	67.53%	68.47%	71.16%	23.55%	-190.02%	28.04%	28.42%
Augmented Payout Ratio	28.08%	45.14%	37.25%	226.01%	67.53%	68.47%	73.80%	23.55%	-190.02%	28.04%	70.61%

This table displays calculated financial ratios and metrics derived from Quaker Chemical's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.61%	8.45%	5.48%	0.62%	-0.33%	-3.65%	-6.08%	-6.43%	-5.78%	-4.93%
EBITDA Growth	9.49%	-167.69%	39.85%	64.19%	20.19%	288.49%	13.87%	8.48%	-4.81%	-26.33%
EBIT Growth	21.92%	-284.11%	75.35%	126.30%	27.10%	182.84%	18.70%	10.68%	-7.58%	-39.14%
NOPAT Growth	-8.53%	-283.31%	41.36%	27.48%	28.19%	158.51%	11.75%	5.08%	-10.57%	-29.37%
Net Income Growth	-16.62%	-518.97%	49.04%	104.53%	30.11%	126.64%	19.35%	18.77%	-3.97%	-29.85%
EPS Growth	-16.76%	-519.80%	47.75%	103.75%	29.86%	126.42%	18.90%	19.02%	-3.21%	-27.68%
Operating Cash Flow Growth	-247.97%	46.66%	699.81%	3,785.03%	566.75%	16.85%	-27.93%	-40.84%	-18.50%	-20.73%
Free Cash Flow Firm Growth	134.21%	85.22%	303.97%	789.51%	340.39%	2,410.13%	-13.49%	-30.00%	-90.63%	-39.87%
Invested Capital Growth	-0.74%	-1.54%	-5.43%	-5.72%	-8.16%	-6.14%	-4.50%	-3.57%	0.92%	-3.81%
Revenue Q/Q Growth	-0.03%	-1.51%	3.16%	-0.94%	-0.98%	-4.79%	0.57%	-1.32%	-0.28%	-3.93%
EBITDA Q/Q Growth	43.33%	-154.97%	291.98%	8.54%	4.92%	-13.79%	15.98%	3.40%	-7.93%	-33.27%
EBIT Q/Q Growth	90.15%	-224.62%	185.62%	11.53%	6.80%	-18.78%	22.69%	4.00%	-10.82%	-46.51%
NOPAT Q/Q Growth	9.44%	-216.93%	196.23%	3.53%	10.05%	-46.63%	83.80%	-2.66%	-6.35%	-57.85%
Net Income Q/Q Growth	80.28%	-393.12%	138.90%	-0.50%	14.69%	-39.99%	74.30%	-0.99%	-7.27%	-56.17%
EPS Q/Q Growth	80.00%	-394.44%	138.68%	-0.61%	14.72%	-40.11%	74.11%	-0.51%	-6.70%	-55.25%
Operating Cash Flow Q/Q Growth	-741.34%	481.01%	-44.51%	107.16%	6.56%	-4.61%	-65.77%	70.04%	46.82%	-7.23%
Free Cash Flow Firm Q/Q Growth	170.74%	-113.22%	2,498.08%	3.66%	34.04%	-30.67%	-10.19%	-16.13%	-82.06%	345.04%
Invested Capital Q/Q Growth	-0.73%	-2.56%	-0.61%	-1.93%	-3.30%	-0.41%	1.12%	-0.98%	1.20%	-5.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.66%	32.23%	34.68%	35.87%	37.37%	36.64%	38.65%	37.91%	37.33%	35.17%
EBITDA Margin	13.15%	-7.34%	13.65%	14.96%	15.85%	14.35%	16.55%	17.35%	16.01%	11.12%
Operating Margin	9.06%	-11.06%	9.98%	11.46%	12.13%	10.33%	11.82%	12.61%	11.19%	6.53%
EBIT Margin	9.08%	-11.49%	9.54%	10.74%	11.58%	9.88%	12.05%	12.70%	11.36%	6.32%
Profit (Net Income) Margin	5.26%	-15.66%	5.91%	5.93%	6.87%	4.33%	7.51%	7.53%	7.00%	3.20%
Tax Burden Percent	71.36%	111.60%	85.76%	72.63%	76.57%	59.17%	77.01%	72.55%	76.79%	74.66%
Interest Burden Percent	81.23%	122.17%	72.23%	76.08%	77.50%	74.09%	80.88%	81.73%	80.29%	67.68%
Effective Tax Rate	28.05%	0.00%	27.67%	34.18%	30.88%	54.50%	27.32%	32.79%	28.86%	46.55%
Return on Invested Capital (ROIC)	6.04%	-7.48%	6.97%	7.42%	8.41%	4.74%	8.51%	8.38%	7.84%	3.49%
ROIC Less NNEP Spread (ROIC-NNEP)	5.19%	-13.13%	6.01%	6.23%	7.27%	4.46%	7.64%	7.58%	6.95%	3.21%
Return on Net Nonoperating Assets (RNNOA)	2.83%	-6.69%	3.04%	3.14%	3.64%	2.02%	3.31%	3.03%	2.48%	1.10%
Return on Equity (ROE)	8.87%	-14.17%	10.00%	10.56%	12.05%	6.76%	11.82%	11.41%	10.32%	4.59%
Cash Return on Invested Capital (CROIC)	5.88%	-4.95%	3.43%	5.79%	8.90%	13.39%	11.91%	11.16%	6.47%	11.10%
Operating Return on Assets (OROA)	5.99%	-7.73%	6.41%	7.35%	8.20%	6.97%	8.32%	8.79%	7.74%	4.37%
Return on Assets (ROA)	3.48%	-10.54%	3.97%	4.06%	4.87%	3.06%	5.18%	5.21%	4.77%	2.21%
Return on Common Equity (ROCE)	8.86%	-14.16%	10.00%	10.56%	12.04%	6.76%	11.82%	11.40%	10.32%	4.59%
Return on Equity Simple (ROE_SIMPLE)	6.12%	0.00%	-0.47%	0.67%	1.25%	0.00%	8.52%	8.90%	8.49%	0.00%
Net Operating Profit after Tax (NOPAT)	32	-38	36	37	41	22	40	39	37	16
NOPAT Margin	6.52%	-7.74%	7.22%	7.55%	8.39%	4.70%	8.59%	8.47%	7.96%	3.49%
Net Nonoperating Expense Percent (NNEP)	0.85%	5.65%	0.96%	1.19%	1.13%	0.29%	0.87%	0.80%	0.89%	0.28%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.66%	-	-	-	1.02%	-	-	-	0.75%
Cost of Revenue to Revenue	67.34%	67.77%	65.32%	64.14%	62.63%	63.36%	61.35%	62.09%	62.67%	64.83%
SG&A Expenses to Revenue	23.46%	24.98%	23.90%	24.19%	25.03%	25.98%	26.43%	25.23%	25.57%	28.25%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.60%	43.29%	24.70%	24.40%	25.24%	26.31%	26.83%	25.30%	26.14%	28.64%
Earnings before Interest and Taxes (EBIT)	45	-56	48	53	57	46	57	59	53	28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	65	-36	68	74	78	67	78	80	74	49
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.98	2.29	2.66	2.59	2.12	2.74	2.64	2.18	2.08	1.84
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	270.23	78.50	329.33
Price to Revenue (P/Rev)	1.33	1.50	1.78	1.75	1.44	1.94	1.91	1.61	1.62	1.36
Price to Earnings (P/E)	32.47	0.00	0.00	393.78	171.28	33.58	31.03	24.56	24.53	21.39
Dividend Yield	1.17%	1.03%	0.87%	0.89%	1.10%	0.84%	0.87%	1.06%	1.08%	1.32%
Earnings Yield	3.08%	0.00%	0.00%	0.25%	0.58%	2.98%	3.22%	4.07%	4.08%	4.68%
Enterprise Value to Invested Capital (EV/IC)	1.61	1.82	2.10	2.09	1.79	2.28	2.20	1.88	1.82	1.63
Enterprise Value to Revenue (EV/Rev)	1.73	1.87	2.11	2.06	1.71	2.19	2.17	1.86	1.85	1.60
Enterprise Value to EBITDA (EV/EBITDA)	15.62	29.52	29.20	23.69	18.29	14.86	14.06	11.62	11.54	10.43
Enterprise Value to EBIT (EV/EBIT)	26.26	91.56	69.16	45.22	33.10	20.94	19.61	16.11	16.13	14.97
Enterprise Value to NOPAT (EV/NOPAT)	31.24	0.00	0.00	0.00	444.03	31.24	29.43	24.48	24.73	22.11
Enterprise Value to Operating Cash Flow (EV/OCF)	163.92	86.96	48.47	24.44	12.62	15.30	15.54	14.88	15.63	14.35
Enterprise Value to Free Cash Flow (EV/FCFF)	27.30	0.00	59.47	35.00	19.30	16.47	18.05	16.50	28.22	14.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.76	0.77	0.71	0.66	0.61	0.56	0.57	0.54	0.53	0.54
Long-Term Debt to Equity	0.75	0.75	0.70	0.65	0.60	0.54	0.55	0.52	0.50	0.51
Financial Leverage	0.54	0.51	0.51	0.50	0.50	0.45	0.43	0.40	0.36	0.34
Leverage Ratio	2.17	2.17	2.16	2.16	2.12	2.08	2.06	2.00	1.96	1.94
Compound Leverage Factor	1.76	2.65	1.56	1.64	1.65	1.54	1.66	1.63	1.58	1.32
Debt to Total Capital	43.31%	43.38%	41.68%	39.79%	38.06%	35.94%	36.24%	35.19%	34.45%	34.94%
Short-Term Debt to Total Capital	0.91%	0.85%	0.86%	0.87%	0.89%	1.08%	1.27%	1.51%	1.76%	1.80%
Long-Term Debt to Total Capital	42.40%	42.53%	40.82%	38.92%	37.18%	34.86%	34.97%	33.68%	32.69%	33.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	56.66%	56.59%	58.29%	60.18%	61.90%	64.03%	63.74%	64.78%	65.52%	65.03%
Debt to EBITDA	4.63	7.96	6.60	5.15	4.46	2.71	2.67	2.50	2.54	2.58
Net Debt to EBITDA	3.61	5.77	4.63	3.51	2.89	1.68	1.67	1.56	1.49	1.56
Long-Term Debt to EBITDA	4.53	7.80	6.46	5.04	4.36	2.62	2.57	2.39	2.41	2.45
Debt to NOPAT	9.26	-7.49	-21.44	-445.47	108.42	5.69	5.58	5.27	5.44	5.48
Net Debt to NOPAT	7.21	-5.43	-15.05	-303.57	70.10	3.52	3.50	3.29	3.18	3.32
Long-Term Debt to NOPAT	9.06	-7.34	-21.00	-435.70	105.89	5.52	5.39	5.04	5.16	5.19
Altman Z-Score	2.24	2.27	2.62	2.73	2.56	3.02	3.00	2.78	2.72	2.50
Noncontrolling Interest Sharing Ratio	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.69	2.80	2.79	2.84	2.74	2.52	2.66	2.63	2.54	2.31
Quick Ratio	1.64	1.84	1.82	1.86	1.83	1.74	1.82	1.75	1.71	1.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	47	-6.25	150	155	208	144	130	109	20	87
Operating Cash Flow to CapEx	-349.57%	985.20%	613.24%	719.46%	952.80%	4,354.68%	618.61%	1,179.99%	827.71%	306.45%
Free Cash Flow to Firm to Interest Expense	5.64	-0.51	11.33	12.22	16.31	12.09	11.99	10.12	1.89	9.57
Operating Cash Flow to Interest Expense	-2.13	5.51	2.85	6.15	6.53	6.66	2.52	4.31	6.57	6.95
Operating Cash Flow Less CapEx to Interest Expense	-2.74	4.95	2.39	5.30	5.84	6.50	2.11	3.94	5.78	4.68
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.67	0.67	0.68	0.71	0.71	0.69	0.69	0.68	0.69
Accounts Receivable Turnover	4.26	4.30	4.19	4.29	4.34	4.26	4.17	4.31	4.29	4.35
Inventory Turnover	4.58	4.85	4.48	4.43	4.51	4.81	4.53	4.59	4.69	5.00
Fixed Asset Turnover	10.05	9.81	9.84	9.93	10.24	9.61	9.49	9.33	9.04	8.41
Accounts Payable Turnover	6.11	6.33	5.65	5.93	6.41	6.59	5.93	6.22	6.08	6.03
Days Sales Outstanding (DSO)	85.76	84.84	87.21	85.08	84.11	85.75	87.58	84.75	85.16	83.83
Days Inventory Outstanding (DIO)	79.66	75.33	81.44	82.32	80.96	75.87	80.59	79.56	77.88	72.98
Days Payable Outstanding (DPO)	59.73	57.68	64.59	61.58	56.94	55.41	61.55	58.68	59.99	60.58
Cash Conversion Cycle (CCC)	105.68	102.50	104.06	105.82	108.13	106.22	106.62	105.63	103.05	96.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,049	1,997	1,985	1,946	1,882	1,874	1,895	1,877	1,899	1,803
Invested Capital Turnover	0.93	0.97	0.96	0.98	1.00	1.01	0.99	0.99	0.99	1.00
Increase / (Decrease) in Invested Capital	-15	-31	-114	-118	-167	-123	-89	-70	17	-71
Enterprise Value (EV)	3,300	3,635	4,163	4,064	3,376	4,268	4,171	3,519	3,454	2,936
Market Capitalization	2,537	2,923	3,502	3,461	2,842	3,786	3,675	3,046	3,009	2,495
Book Value per Share	$71.34	$71.27	$73.32	$74.30	$74.48	$76.97	$77.33	$77.54	$80.71	$76.10
Tangible Book Value per Share	($12.72)	($10.04)	($7.66)	($4.98)	($3.03)	($1.39)	($0.97)	$0.63	$2.14	$0.43
Total Capital	2,257	2,258	2,258	2,220	2,165	2,162	2,183	2,153	2,206	2,081
Total Debt	978	980	941	883	824	777	791	758	760	727
Total Long-Term Debt	957	961	922	864	805	754	763	725	721	690
Net Debt	762	711	660	602	533	481	495	473	445	440
Capital Expenditures (CapEx)	5.11	6.91	6.16	11	8.75	1.83	4.40	3.92	8.21	21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	501	478	489	467	435	389	415	413	397	345
Debt-free Net Working Capital (DFNWC)	639	659	679	657	633	584	611	601	609	534
Net Working Capital (NWC)	619	639	660	637	614	560	583	569	571	497
Net Nonoperating Expense (NNE)	6.19	38	6.57	7.99	7.43	1.73	5.10	4.37	4.42	1.32
Net Nonoperating Obligations (NNO)	770	718	668	610	541	490	504	481	453	449
Total Depreciation and Amortization (D&A)	20	20	21	21	21	21	21	22	22	21
Debt-free, Cash-free Net Working Capital to Revenue	26.26%	24.57%	24.85%	23.70%	22.07%	19.93%	21.57%	21.83%	21.32%	18.77%
Debt-free Net Working Capital to Revenue	33.55%	33.89%	34.49%	33.30%	32.14%	29.89%	31.75%	31.81%	32.71%	29.04%
Net Working Capital to Revenue	32.48%	32.90%	33.50%	32.32%	31.16%	28.69%	30.31%	30.09%	30.63%	27.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.44	($4.24)	$1.64	$1.63	$1.87	$1.13	$1.96	$1.94	$1.81	$0.80
Adjusted Weighted Average Basic Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M
Adjusted Diluted Earnings per Share	$1.44	($4.24)	$1.64	$1.63	$1.87	$1.12	$1.95	$1.94	$1.81	$0.81
Adjusted Weighted Average Diluted Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.93M	17.95M	17.98M	18.00M	17.98M	17.99M	17.99M	17.91M	17.79M	17.67M
Normalized Net Operating Profit after Tax (NOPAT)	33	-40	39	38	42	35	42	39	39	16
Normalized NOPAT Margin	6.62%	-8.35%	7.79%	7.68%	8.53%	7.46%	8.88%	8.52%	8.36%	3.70%
Pre Tax Income Margin	7.38%	-14.04%	6.89%	8.17%	8.97%	7.32%	9.75%	10.38%	9.12%	4.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.33	-4.51	3.60	4.18	4.44	3.86	5.23	5.47	5.07	3.09
NOPAT to Interest Expense	3.83	-3.04	2.73	2.94	3.22	1.84	3.73	3.65	3.56	1.71
EBIT Less CapEx to Interest Expense	4.72	-5.07	3.14	3.33	3.76	3.71	4.82	5.11	4.28	0.83
NOPAT Less CapEx to Interest Expense	3.22	-3.60	2.26	2.08	2.53	1.68	3.32	3.29	2.76	-0.56
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	38.00%	-190.02%	-497.94%	346.88%	187.16%	28.04%	27.01%	26.10%	26.65%	28.42%
Augmented Payout Ratio	38.00%	-190.02%	-497.94%	346.88%	187.16%	28.04%	27.01%	26.10%	26.65%	70.61%

Frequently Asked Questions About Quaker Chemical's Financials

When does Quaker Chemical's fiscal year end?

According to the most recent income statement we have on file, Quaker Chemical's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Quaker Chemical's net income changed over the last 10 years?

Quaker Chemical's net income appears to be on an upward trend, with a most recent value of $116.73 million in 2024, rising from $58.30 million in 2014. The previous period was $112.87 million in 2023.

What is Quaker Chemical's operating income?

Quaker Chemical's total operating income in 2024 was $194.71 million, based on the following breakdown:

Total Gross Profit: $686.03 million
Total Operating Expenses: $491.32 million

How has Quaker Chemical revenue changed over the last 10 years?

Over the last 10 years, Quaker Chemical's total revenue changed from $765.86 million in 2014 to $1.84 billion in 2024, a change of 140.2%.

How much debt does Quaker Chemical have?

Quaker Chemical's total liabilities were at $1.26 billion at the end of 2024, a 5.5% decrease from 2023, and a 318.3% increase since 2014.

How much cash does Quaker Chemical have?

In the past 10 years, Quaker Chemical's cash and equivalents has ranged from $64.73 million in 2014 to $194.53 million in 2023, and is currently $188.88 million as of their latest financial filing in 2024.

How has Quaker Chemical's book value per share changed over the last 10 years?

Over the last 10 years, Quaker Chemical's book value per share changed from 26.94 in 2014 to 76.10 in 2024, a change of 182.5%.

Remove Ads

Related Companies

This page (NYSE:KWR) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quaker Chemical (KWR) Financials

Frequently Asked Questions About Quaker Chemical's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quaker Chemical (KWR) Financials

Annual Income Statements for Quaker Chemical

Quarterly Income Statements for Quaker Chemical

Annual Cash Flow Statements for Quaker Chemical

Quarterly Cash Flow Statements for Quaker Chemical

Annual Balance Sheets for Quaker Chemical

Quarterly Balance Sheets for Quaker Chemical

Annual Metrics and Ratios for Quaker Chemical

Quarterly Metrics and Ratios for Quaker Chemical

Frequently Asked Questions About Quaker Chemical's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools